| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Aaron S Kelly, Andrea M Thelen, Daniel R Kaiser, J Michael Gonzalez-Campoy, Alan J Ban. Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus. Vascular medicine (London, England). vol 12. issue 4. 2008-03-20. PMID:18048467. |
the following variables were measured pre- and post-treatment: glucose, insulin, homeostasis model assessment (homa), hemoglobin a1c (hba1c), c-peptide, blood pressure, lipids, c-reactive protein (crp), adma, 8-isoprostane, oxidized ldl cholesterol, brachial artery flow-mediated dilation (fmd), endothelium-independent dilation (eid), and brachial and carotid artery stiffness. |
2008-03-20 |
2023-08-12 |
Not clear |
| Hamiyet Yilmaz, Alptekin Gursoy, Mustafa Sahin, Nilgun Guvener Demira. Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes. Acta diabetologica. vol 44. issue 4. 2008-03-12. PMID:17726570. |
the aim of this study was to compare the efficacy of treatment with insulin alone, insulin plus acarbose, insulin plus metformin, or insulin plus rosiglitazone in type 2 diabetic subjects who were previously on insulin monotherapy, and to evaluate the effects of these treatments on cardiovascular risk factors including lipid profile, c-reactive protein (crp) and fibrinogen. |
2008-03-12 |
2023-08-12 |
human |
| Hamiyet Yilmaz, Alptekin Gursoy, Mustafa Sahin, Nilgun Guvener Demira. Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes. Acta diabetologica. vol 44. issue 4. 2008-03-12. PMID:17726570. |
crp and fibrinogen levels decreased in all groups, but the decrease in fibrinogen level was significantly greater in insulin plus rosiglitazone group. |
2008-03-12 |
2023-08-12 |
human |
| Yuan-Xiang Meng, Earl S Ford, Chaoyang Li, Alexander Quarshie, Ahmad M Al-Mahmoud, Wayne Giles, Gary H Gibbons, Gregory Strayhor. Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002. Clinical chemistry. vol 53. issue 12. 2008-03-10. PMID:17951292. |
increased c-reactive protein (crp) concentration and insulin resistance (ir) are associated with increased rates of adverse cardiovascular events. |
2008-03-10 |
2023-08-12 |
Not clear |
| Hisashi Makino, Kentaro Doi, Aki Hiuge, Ayako Nagumo, Sadanori Okada, Yoshihiro Miyamoto, Masaaki Suzuki, Yasunao Yoshimas. Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria. Diabetes research and clinical practice. vol 79. issue 1. 2008-03-07. PMID:17904244. |
we evaluated flow-mediated dilatation of brachial artery (%fmd, one endothelial function marker associated with endogenous no production), von willebrand factor (vwf, endothelial activation marker), high-sensitive crp (hscrp, a low-grade inflammation marker), asymmetric dimethyl arginine (adma, an endogenous inhibitor of no synthesis), and insulin sensitivity by steady-state plasma glucose method. |
2008-03-07 |
2023-08-12 |
Not clear |
| Jerry R Greenfield, Lesley V Campbel. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Current diabetes reviews. vol 2. issue 2. 2008-02-27. PMID:18220627. |
this conclusion is predominantly drawn from studies demonstrating associations between elevated (but 'normal range') levels of circulating acute phase inflammatory markers, typified by c-reactive protein (crp), and indices of insulin resistance and the development of type 2 diabetes. |
2008-02-27 |
2023-08-12 |
Not clear |
| Jerry R Greenfield, Lesley V Campbel. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Current diabetes reviews. vol 2. issue 2. 2008-02-27. PMID:18220627. |
in this review, we present evidence to support the suggestion that body fat is the primary determinant of circulating inflammatory marker levels in the basal state and that marginally elevated levels of circulating interleukin-6 and crp in obesity are a consequence rather than a cause of insulin resistance. |
2008-02-27 |
2023-08-12 |
Not clear |
| D A de Luis, M G Sagrado, R Aller, O Izaola, R Cond. Influence of ALA54THR polymorphism of fatty acid-binding protein 2 on obesity and cardiovascular risk factors. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 39. issue 11. 2008-02-14. PMID:17992640. |
an indirect calorimetry, tetrapolar electrical bioimpedance, blood pressure, a serial assessment of nutritional intake with 3 days of written food records, and biochemical analysis (lipid profile, adipocytokines, insulin, crp, and lipoprotein-a) were performed. |
2008-02-14 |
2023-08-12 |
Not clear |
| C Bulcão, F M A Giuffrida, F F Ribeiro-Filho, S R G Ferreir. Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity? Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 40. issue 2. 2008-01-31. PMID:17273659. |
the objective of the present study was to evaluate the effect of simvastatin therapy on insulin resistance and on leptin, adiponectin, and c-reactive protein (crp) levels, as compared to metformin, in overweight pre-diabetic subjects. |
2008-01-31 |
2023-08-12 |
human |
| K Krzyzanowska, F Mittermayer, W Krugluger, M Roden, G Schernthaner, M Wolz. Adiponectin concentrations increase during acute FFA elevation in humans treated with rosiglitazone. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 39. issue 10. 2008-01-16. PMID:17952842. |
blood for determination of adiponectin, c-reactive protein (crp), leptin, resistin, ffas, glucose, and insulin was drawn at baseline and on day 21 before and after 5 hours of triglyceride/heparin infusion. |
2008-01-16 |
2023-08-12 |
human |
| Mitsuhisa Komatsu, Hirokazu Ohfusa, Toru Aizawa, Kiyoshi Hashizum. Adiponectin inversely correlates with high sensitive C-reactive protein and triglycerides, but not with insulin sensitivity, in apparently healthy Japanese men. Endocrine journal. vol 54. issue 4. 2008-01-14. PMID:17575367. |
to explore physiological and pathophysiological significance of adiponectin in the japanese general population, we systematically analyzed the relationship between adiponectin and high sensitive crp (hscrp), lipids, insulin sensitivity, and anthropometric parameters in 166 consecutive adult male health examinees. |
2008-01-14 |
2023-08-12 |
human |
| C P Fischer, A Berntsen, L B Perstrup, P Eskildsen, B K Pederse. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scandinavian journal of medicine & science in sports. vol 17. issue 5. 2008-01-08. PMID:17076827. |
obesity was associated with elevated insulin, c-peptide, triglycerides, low-density lipoprotein, il-6, crp, and adiponectin (all p<0.05). |
2008-01-08 |
2023-08-12 |
human |
| I-Te Lee, Wen-Jane Lee, Chien-Ning Huang, Wayne H-H She. The association of low-grade inflammation, urinary albumin, and insulin resistance with metabolic syndrome in nondiabetic Taiwanese. Metabolism: clinical and experimental. vol 56. issue 12. 2008-01-08. PMID:17998025. |
we therefore conducted a cross-sectional study to investigate the accumulative effect and the correlation of components of the metabolic syndrome to c-reactive protein (crp), urinary albumin excretion (uae), and the homeostasis model assessment for insulin resistance index (homa-ir). |
2008-01-08 |
2023-08-12 |
human |
| Lewis H Kuller, Gregory Grandits, Jerome D Cohen, James D Neaton, Ronald Prinea. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis. vol 195. issue 1. 2007-12-07. PMID:17011566. |
we tested the hypotheses whether nuclear magnetic resonance (nmr) determined lipoprotein particles, insulin and adiponectin, and c-reactive protein (crp) and white blood cell (wbc) count as markers of inflammation predicted risk of coronary heart disease (chd) death among 428 men age 35-57 years with metabolic syndrome (metsyn) in a matched case control study within the multiple risk factor intervention trial. |
2007-12-07 |
2023-08-12 |
Not clear |
| Lewis H Kuller, Gregory Grandits, Jerome D Cohen, James D Neaton, Ronald Prinea. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis. vol 195. issue 1. 2007-12-07. PMID:17011566. |
elevated ldl cholesterol (ldl-c), smoking and wbc count were, but levels of adiponectin, insulin and crp were not significantly related to chd death. |
2007-12-07 |
2023-08-12 |
Not clear |
| J C Woodworth, M D Tokach, J L Nelssen, R D Goodband, S S Dritz, S I Koo, J E Minton, K Q Owe. Influence of dietary L-carnitine and chromium picolinate on blood hormones and metabolites of gestating sows fed one meal per day. Journal of animal science. vol 85. issue 10. 2007-11-09. PMID:17565063. |
postfeeding and overall insulin and connecting peptide of insulin (c-peptide) was decreased for sows fed diets with crp or l-carnitine and was greatest for sows fed the control diet; however, sows fed both l-carnitine and crp had an intermediate response (l-carnitine x crp, p < 0.01). |
2007-11-09 |
2023-08-12 |
Not clear |
| C D'Alessandris, R Lauro, I Presta, G Sest. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia. vol 50. issue 4. 2007-11-07. PMID:17279354. |
c-reactive protein (crp) is associated with insulin resistance and predicts development of type 2 diabetes. |
2007-11-07 |
2023-08-12 |
human |
| C D'Alessandris, R Lauro, I Presta, G Sest. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia. vol 50. issue 4. 2007-11-07. PMID:17279354. |
however, it is unknown whether crp directly affects insulin signalling action. |
2007-11-07 |
2023-08-12 |
human |
| C D'Alessandris, R Lauro, I Presta, G Sest. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia. vol 50. issue 4. 2007-11-07. PMID:17279354. |
to this aim, we determined the effects of human recombinant crp (hrcrp) on insulin signalling involved in glucose transport in l6 myotubes. |
2007-11-07 |
2023-08-12 |
human |
| Guoyue Yuan, Xia Chen, Qinyun Ma, Jie Qiao, Rongying Li, Xuesong Li, Shengxian Li, Jinfeng Tang, Libin Zhou, Huaidong Song, Mingdao Che. C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes. The Journal of endocrinology. vol 194. issue 2. 2007-10-25. PMID:17641277. |
these results collectively suggest that crp suppresses adiponectin gene expression partially through the pi-3 kinase pathway, and that decreased production of adiponectin might represent a mechanism by which crp regulates insulin sensitivity. |
2007-10-25 |
2023-08-12 |
Not clear |